Among them, the SHM2 subtype was characterized by an abundance of alterations in the BCR signaling pathway and harbored the highest frequency of MYD88 (L265P) and CD79B mutations, in addition to other alterations that characterize the ABC subtype, resembling the results described for MCD and C5 groups, respectively. Here, BCR is linked to aneurysmal bone cyst.